Eduardo Glatstein

Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody, against Shiga-Like Toxin 2 in Healthy Adults and in Pediatric Patients Infected with Shiga-Like Toxin-Producing <i>Escherichia coli</i>

Eduardo López, María M Contrini, Eduardo Glatstein et al. · Antimicrobial Agents and Chemotherapy · 2009 · 103 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +11

An Epidemiologic Surveillance of Shiga-like Toxin-producing Escherichia coli Infection in Argentinean Children

Eduardo López, María M Contrini, Eduardo Glatstein et al. · The Pediatric Infectious Disease Journal · 2011 · 50 citations

Life Sciences, Infectious Diseases, Pediatrics +17

Rapid Decrease in Rates of Hospitalization Resulting From Invasive Pneumococcal Disease and Community-Acquired Pneumonia in Children Aged &lt;60 Months After 13-Valent Pneumococcal Conjugate Vaccine Introduction in Argentina

Eduardo López, Eduardo Glatstein, Gustavo Ezcurra et al. · Journal of the Pediatric Infectious Diseases Society · 2017 · 19 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17

Phase I trial of Staphylococcus aureus Cowan I immunoperfusion.

Gerald L. Messerschmidt, C Bowles, D. L. Dean et al. · PubMed · 1982 · 13 citations

Life Sciences, Immunology, Pharmacology +14